Biomarkers profile in provoked versus unprovoked deep venous thrombosis

Tavares, Isabela Rodrigues; Caffaro, Roberto Augusto; Portugal, Maria Fernanda; Ribeiro, Camilla Moreira; da Silva, Viviane Santana; Krupa, Emily; Nikolovski, Srdjan; de Britto, Karen Falcão; Gomes Pereira Petisco, Ana Cláudia; Miranda, Maria Cristina; Santos, Sandra Gomes de Souza; Dourado, Marcela da Silva; Siqueira, Paula Veloso; Siddiqui, Fakiha; Fareed, Jawed; Ramacciotti, Eduardo.
Clin. appl. thromb. hemost ; 30: 1-8, 2024. ilus, tab
Artículo en Inglés | CONASS, SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1554570

Documentos relacionados

  1. Biomarkers Profile in Provoked <i>Versus</i> Unprovoked Deep Venous Thrombosis.
  2. [Consolidate the foundation, steadily promote and comprehensively improve the quality control in prevention and management of venous thromboembolism in China].
  3. Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study.
  4. Enoxaparin may be associated with lower rates of mortality than unfractionated heparin in neurocritical and surgical patients.
  5. Six-week low-molecular-weight heparin versus 12-week warfarin for calf deep vein thrombosis: A randomized, prospective, open-label study.
  6. [Pulmonary embolism and direct oral anticoagulants].
  7. Preoperative low-molecular weight heparin chemoprophylaxis in head and neck free flap reconstruction.
  8. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
  9. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation.
  10. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation.